Pro-inflammatory S100A8 and S100A9 proteins: Self-assembly into multifunctional native and amyloid complexes

International Journal of Molecular Sciences

Volumn 13, Issue 3, 2012, Pages 2893-2917

  Vogl, Thomas ^a   Gharibyan, Anna L ^b   Morozova Roche, Ludmilla A ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Amyloid; Calcium binding; Calprotectin; Cancer; Inflammation; S100 proteins; S100A8; S100A9; Selfassembly

Indexed keywords

AMYLOID; CALCIUM ION; CALGRANULIN A; CALGRANULIN B; ZINC ION; AUTACOID; MULTIPROTEIN COMPLEX;

AGING; AMINO ACID SEQUENCE; AUTOIMMUNE DISEASE; BINDING COMPETITION; BINDING SITE; BONE MARROW CELL; CALCIUM BINDING; CELLULAR DISTRIBUTION; COMPLEX FORMATION; COVALENT BOND; CYTOSOL; DEGENERATIVE DISEASE; DIMERIZATION; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; MALIGNANT NEOPLASTIC DISEASE; METAL BINDING; MOLECULAR PATHOLOGY; NONHUMAN; OLIGOMERIZATION; PHAGOCYTE; POLYMERIZATION; PROSTATE; PROSTATE HYPERTROPHY; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; PROTEIN SYNTHESIS REGULATION; PROTEIN TARGETING; REVIEW; STRUCTURE ACTIVITY RELATION; TETRAMERISATION; TISSUE DISTRIBUTION; ANIMAL; CHEMISTRY; METABOLISM; PROTEIN MULTIMERIZATION;

AMYLOID; ANIMALS; CALGRANULIN A; CALGRANULIN B; HUMANS; INFLAMMATION MEDIATORS; MULTIPROTEIN COMPLEXES; PROTEIN MULTIMERIZATION;

EID: 84858976137     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13032893     Document Type: Review

References (120)

1. Grevers, L.C.; de Vries, T.J.; Vogl, T.; Abdollahi-Roodsaz, S.; Sloetjes, A.W.; Leenen, P.J.; Roth, J.; Everts, V.; van den Berg, W.B.; van Lent, P.L. S100A8 enhances osteoclastic bone resorption in vitro through activation of Toll-like receptor 4: Implications for bone destruction in murine antigen-induced arthritis. Arthritis Rheum. 2011, 63, 1365-1375.
2. Hiratsuka, S.; Watanabe, A.; Aburatani, H.; Maru, Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 2006, 8, 1369-1375.
3. Hoyaux, D.; Decaestecker, C.; Heizmann, C.W.; Vogl, T.; Schafer, B.W.; Salmon, I.; Kiss, R.; Pochet, R. S100 proteins in Corpora amylacea from normal human brain. Brain Res. 2000, 867, 280-288.
4. Salama, I.; Malone, P.S.; Mihaimeed, F.; Jones, J.L. A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 2008, 34, 357-364.
5. van Lent, P.L.; Grevers, L.; Blom, A.B.; Sloetjes, A.; Mort, J.S.; Vogl, T.; Nacken, W.; van den Berg, W.B.; Roth, J. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann. Rheum. Dis. 2008, 67, 1750-1758.
6. Vogl, T.; Ludwig, S.; Goebeler, M.; Strey, A.; Thorey, I.S.; Reichelt, R.; Foell, D.; Gerke, V.; Manitz, M.P.; Nacken, W.; et al. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 2004, 104, 4260-4268.
7. Fritz, G.; Botelho, H.M.; Morozova-Roche, L.A.; Gomes, C.M. Natural and amyloid self-assembly of S100 proteins: Structural basis of functional diversity. FEBS J. 2010, 277, 4578-4590.
8. Ravasi, T.; Hsu, K.; Goyette, J.; Schroder, K.; Yang, Z.; Rahimi, F.; Miranda, L.P.; Alewood, P.F.; Hume, D.A.; Geczy, C. Probing the S100 protein family through genomic and functional analysis. Genomics 2004, 84, 10-22.
9. Yan, W.X.; Armishaw, C.; Goyette, J.; Yang, Z.; Cai, H.; Alewood, P.; Geczy, C.L. Mast cell and monocyte recruitment by S100A12 and its hinge domain. J. Biol. Chem. 2008, 283, 13035-13043.
10. Potts, B.C.; Carlstrom, G.; Okazaki, K.; Hidaka, H.; Chazin, W.J. 1H NMR assignments of apo calcyclin and comparative structural analysis with calbindin D9k and S100 beta. Protein Sci. 1996, 5, 2162-2174.
11. Botelho, H.M.; Koch, M.; Fritz, G.; Gomes, C.M. Metal ions modulate the folding and stability of the tumor suppressor protein S100A2. FEBS J. 2009, 276, 1776-1786.
12. 2+-and Cu2+-binding protein family. BioMetals 1998, 11, 383-397.
13. Strupat, K.; Rogniaux, H.; van Dorsselaer, A.; Roth, J.; Vogl, T. Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 are confirmed by electrospray ionization-mass analysis. J. Am. Soc. Mass Spectrom. 2000, 11, 780-788.
14. Vogl, T.; Roth, J.; Sorg, C.; Hillenkamp, F.; Strupat, K. Calcium-induced noncovalently linked tetramers of MRP8 and MRP14 detected by ultraviolet matrix-assisted laser desorption/ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 1999, 10, 1124-1130.
15. Yanamandra, K.; Alexeyev, O.; Zamotin, V.; Srivastava, V.; Shchukarev, A.; Brorsson, A.C.; Tartaglia, G.G.; Vogl, T.; Kayed, R.; Wingsle, G., et al. Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate. PloS One 2009, 4, doi:10.1371/journal.pone.0005562.
16. Moore, B.W. A solubel protein characteristics of nervous system. Biochem. Biophys. Res. Commun. 1965, 19, 739-744.
17. Lagasse, E.; Clerc, R.G. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Mol. Cell. Biol. 1988, 8, 2402-2410.
18. Murao, S.; Collart, F.; Huberman, E. A protein complex expressed during terminal differentiation of monomyelocytic cells is an inhibitor of cell growth. Cell Growth Differ. 1990, 1, 447-454.
19. Odink, K.; Cerletti, N.; Bruggen, J.; Clerc, R.G.; Tarcsay, L.; Zwadlo, G.; Gerhards, G.; Schlegel, R.; Sorg, C. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987, 330, 80-82.
20. Wilkinson, M.M.; Busuttil, A.; Hayward, C.; Brock, D.J.; Dorin, J.R.; van Heyningen, V. Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues. J. Cell Sci. 1988, 91, 221-230.
21. Steinbakk, M.; Naess-Andresen, C.F.; Lingaas, E.; Dale, I.; Brandtzaeg, P.; Fagerhol, M.K. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990, 336, 763-765.
22. Lackmann, M.; Cornish, C.J.; Simpson, R.J.; Moritz, R.L.; Geczy, C.L. Purification and structural analysis of a murine chemotactic cytokine (CP-10) with sequence homology to S100 proteins. J. Biol. Chem. 1992, 267, 7499-7504.
23. Marenholz, I.; Lovering, R.C.; Heizmann, C.W. An update of the S100 nomenclature. Biochim. Biophys. Acta 2006, 1763, 1282-1283.
24. Schafer, B.W.; Heizmann, C.W. The S100 family of EF-hand calcium-binding proteins: Functions and pathology. Trends Biochem. Sci. 1996, 21, 134-140.
25. Tufty, R.M.; Kretsinger, R.H. Troponin and parvalbumin calcium binding regions predicted in myosin light chain and T4 lysozyme. Science 1975, 187, 167-169.
26. Hunter, M.J.; Chazin, W.J. High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14. J. Biol. Chem. 1998, 273, 12427-12435.
27. Leukert, N.; Vogl, T.; Strupat, K.; Reichelt, R.; Sorg, C.; Roth, J. Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity. J. Mol. Biol. 2006, 359, 961-972.
28. Ishikawa, K.; Nakagawa, A.; Tanaka, I.; Suzuki, M.; Nishihira, J. The structure of human MRP8, a member of the S100 calcium-binding protein family, by MAD phasing at 1.9 A resolution. Acta Crystallogr. Sect. D Biol. Crystallogr. 2000, 56, 559-566.
29. 2+-dependent regulator protein in inflammatory process. J. Mol. Biol. 2002, 316, 265-276.
30. Strynadka, N.C.; James, M.N. Crystal structures of the helix-loop-helix calcium-binding proteins. Annu. Rev. Biochem. 1989, 58, 951-998.
31. 2+-saturated state. Biochemistry 1997, 36, 3448-3457.
32. 2+ binding to the regulatory domains of cardiac and E41A skeletal muscle troponin C reveal the importance of site I to energetics of the induced structural changes. Biochemistry 1997, 36, 12519-12525.
33. Edgeworth, J.; Freemont, P.; Hogg, N. Ionomycin-regulated phosphorylation of the myeloid calcium-binding protein p14. Nature 1989, 342, 189-192.
34. Guignard, F.; Mauel, J.; Markert, M. Phosphorylation of myeloid-related proteins MRP-14 and MRP-8 during human neutrophil activation. Eur. J. Biochem. 1996, 241, 265-271.
35. 2+-dependent translocation from cytoplasm to membranes and cytoskeleton. J. Immunol. 1996, 156, 1247-1254.
36. Lominadze, G.; Rane, M.J.; Merchant, M.; Cai, J.; Ward, R.A.; McLeish, K.R. Myeloid-related protein-14 is a p38 MAPK substrate in human neutrophils. J. Immunol. 2005, 174, 7257-7267.
37. Sohnle, P.G.; Hunter, M.J.; Hahn, B.; Chazin, W.J. Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). J. Infect. Dis. 2000, 182, 1272-1275.
38. Vogl, T.; Leukert, N.; Barczyk, K.; Strupat, K.; Roth, J. Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations. Biochim. Biophys. Acta 2006, 1763, 1298-1306.
39. Korndorfer, I.P.; Brueckner, F.; Skerra, A. The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting α-helices can determine specific association of two EF-hand proteins. J. Mol. Biol. 2007, 370, 887-898.
40. Kerkhoff, C.; Vogl, T.; Nacken, W.; Sopalla, C.; Sorg, C. Zinc binding reverses the calcium-induced arachidonic acid-binding capacity of the S100A8/A9 protein complex. FEBS Lett. 1999, 460, 134-138.
41. Bianchi, M.; Niemiec, M.J.; Siler, U.; Urban, C.F.; Reichenbach, J. Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent. J. Allergy Clin. Immunol. 2011, 127, 1243-1252.
42. Kehl-Fie, T.E.; Chitayat, S.; Hood, M.I.; Damo, S.; Restrepo, N.; Garcia, C.; Munro, K.A.; Chazin, W.J.; Skaar, E.P. Nutrient metal sequestration by calprotectin inhibits bacterial superoxide defense, enhancing neutrophil killing of Staphylococcus aureus. Cell Host Microbe 2011, 10, 158-164.
43. Wilder, P.T.; Varney, K.M.; Weiss, M.B.; Gitti, R.K.; Weber, D.J. Solution structure of zinc- and calcium-bound rat S100B as determined by nuclear magnetic resonance spectroscopy. Biochemistry 2005, 44, 5690-5702.
44. Ostendorp, T.; Diez, J.; Heizmann, C.W.; Fritz, G. The crystal structures of human S100B in the zinc- and calcium-loaded state at three pH values reveal zinc ligand swapping. Biochim. Biophys. Acta 2011, 1813, 1083-1091.
45. 2+-free states. Biochemistry 1999, 38, 1695-1704.
46. 2+ are essential for S100A12 protein oligomerization and function. BMC Biochem. 2009, 10, doi:10.1186/1471-2091-10-11.
47. Fritz, G.; Heizmann, C.W. 3D Structures of the Calcium and Zinc Binding S100 Proteins. In Handbook of Metalloproteins; John Wiley & Sons: Hoboken, NJ, USA, 2006.
48. Yu, W.H.; Fraser, P.E. S100β interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease. J. Neurosci. 2001, 21, 2240-2246.
49. Roth, J.; Burwinkel, F.; van den Bos, C.; Goebeler, M.; Vollmer, E.; Sorg, C. MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood 1993, 82, 1875-1883.
50. Foell, D.; Roth, J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum. 2004, 50, 3762-3771.
51. Vogl, T.; Tenbrock, K.; Ludwig, S.; Leukert, N.; Ehrhardt, C.; van Zoelen, M.A.; Nacken, W.; Foell, D.; van der Poll, T.; Sorg, C., et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 2007, 13, 1042-1049.
52. Loser, K.; Vogl, T.; Voskort, M.; Lueken, A.; Kupas, V.; Nacken, W.; Klenner, L.; Kuhn, A.; Foell, D.; Sorokin, L., et al. The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat. Med. 2010, 16, 713-717.
53. van Lent, P.L.; Grevers, L.C.; Blom, A.B.; Arntz, O.J.; van de Loo, F.A.; van der Kraan, P.; Abdollahi-Roodsaz, S.; Srikrishna, G.; Freeze, H.; Sloetjes, A., et al. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis. Arthritis Rheum. 2008, 58, 3776-3787.
54. Vogl, T. University of Muenster, Muenster, Germany. Unpublished work, 2010.
55. Propper, C.; Huang, X.; Roth, J.; Sorg, C.; Nacken, W. Analysis of the MRP8-MRP14 protein-protein interaction by the two-hybrid system suggests a prominent role of the C-terminal domain of S100 proteins in dimer formation. J. Biol. Chem. 1999, 274, 183-188.
56. PDB Protein Databank. Available online: http://www.rcsb.org (accessed on 27 November 2011).
57. Image of 1mr8 (Ishikawa, K.; Nakagawa, A.; Tanaka, I.; Suzuki, M.; Nishihira, J. The structure of human MRP8, a member of the S100 calcium-binding protein family, by MAD phasing at 1.9 A resolution. Acta Crystallogr. Sect. D Biol. Crystallogr. 2000, 56, 559-566. created with Jmol: An open-source Java viewer for chemical structures in 3D.
58. 2+-dependent regulator protein in inflammatory process. J. Mol. Biol. 2002, 316, 265-276. created with Jmol: An open-source Java viewer for chemical structures in 3D.
59. Images from 1xk4 (Korndoerfer, I.P.; Brueckner, F.; Skerra, A. The crystal structure of human calprotectin illustrates how sequence variation and small conformational changes can determine specific hetero-association of two EF hand proteins. created with Jmol: An open-source Java viewer for chemical structures in 3D.
60. Jmol: An open-source Java viewer for chemical structures in 3D. Available online: http://www.jmol.org (accessed on 27 November 2011).
61. Vogl, T. University of Muenster, Muenster, Germany. Unpublished work, 2011.
62. 2+-binding proteins of neutrophils and monocytes. J. Leukoc. Biol. 1993, 53, 197-204.
63. Mork, G.; Schjerven, H.; Mangschau, L.; Soyland, E.; Brandtzaeg, P. Proinflammatory cytokines upregulate expression of calprotectin (L1 protein, MRP-8/MRP-14) in cultured human keratinocytes. Br. J. Dermatol. 2003, 149, 484-491.
64. McNeill, E.; Conway, S.J.; Roderick, H.L.; Bootman, M.D.; Hogg, N. Defective chemoattractant-induced calcium signalling in S100A9 null neutrophils. Cell Calcium 2007, 41, 107-121.
65. Manitz, M.P.; Horst, B.; Seeliger, S.; Strey, A.; Skryabin, B.V.; Gunzer, M.; Frings, W.; Schonlau, F.; Roth, J.; Sorg, C., et al. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol. Cell. Biol. 2003, 23, 1034-1043.
66. Hobbs, J.A.; May, R.; Tanousis, K.; McNeill, E.; Mathies, M.; Gebhardt, C.; Henderson, R.; Robinson, M.J.; Hogg, N. Myeloid cell function in MRP-14 (S100A9) null mice. Mol. Cell. Biol. 2003, 23, 2564-2576.
67. Rammes, A.; Roth, J.; Goebeler, M.; Klempt, M.; Hartmann, M.; Sorg, C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J. Biol. Chem. 1997, 272, 9496-9502.
68. Goebeler, M.; Roth, J.; van den Bos, C.; Ader, G.; Sorg, C. Increase of calcium levels in epithelial cells induces translocation of calcium-binding proteins migration inhibitory factor-related protein 8 (MRP8) and MRP14 to keratin intermediate filaments. Biochem. J. 1995, 309, 419-424.
69. Frosch, M.; Strey, A.; Vogl, T.; Wulffraat, N.M.; Kuis, W.; Sunderkotter, C.; Harms, E.; Sorg, C.; Roth, J. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2000, 43, 628-637.
70. Viemann, D.; Strey, A.; Janning, A.; Jurk, K.; Klimmek, K.; Vogl, T.; Hirono, K.; Ichida, F.; Foell, D.; Kehrel, B., et al. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 2005, 105, 2955-2962.
71. Viemann, D.; Barczyk, K.; Vogl, T.; Fischer, U.; Sunderkotter, C.; Schulze-Osthoff, K.; Roth, J. MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program. Blood 2007, 109, 2453-2460.
72. Kane, D.; Roth, J.; Frosch, M.; Vogl, T.; Bresnihan, B.; FitzGerald, O. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. Arthritis Rheum. 2003, 48, 1676-1685.
73. Urban, C.F.; Ermert, D.; Schmid, M.; Abu-Abed, U.; Goosmann, C.; Nacken, W.; Brinkmann, V.; Jungblut, P.R.; Zychlinsky, A. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 2009, 5, doi:10.1371/journal.ppat.1000639.
74. Foell, D.; Wittkowski, H.; Vogl, T.; Roth, J. S100 proteins expressed in phagocytes: A novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 2007, 81, 28-37.
75. Ehrchen, J.M.; Sunderkotter, C.; Foell, D.; Vogl, T.; Roth, J. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J. Leukoc. Biol. 2009, 86, 557-566.
76. Healy, A.M.; Pickard, M.D.; Pradhan, A.D.; Wang, Y.; Chen, Z.; Croce, K.; Sakuma, M.; Shi, C.; Zago, A.C.; Garasic, J., et al. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 2006, 113, 2278-2284.
77. Altwegg, L.A.; Neidhart, M.; Hersberger, M.; Muller, S.; Eberli, F.R.; Corti, R.; Roffi, M.; Sutsch, G.; Gay, S.; von Eckardstein, A.; et al. Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: A novel, early, and sensitive marker of acute coronary syndromes. Eur. Heart J. 2007, 28, 941-948.
78. Morrow, D.A.; Wang, Y.; Croce, K.; Sakuma, M.; Sabatine, M.S.; Gao, H.; Pradhan, A.D.; Healy, A.M.; Buros, J.; McCabe, C.H., et al. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. Am. Heart J. 2008, 155, 49-55.
79. Gebhardt, C.; Nemeth, J.; Angel, P.; Hess, J. S100A8 and S100A9 in inflammation and cancer. Biochem. Pharmacol. 2006, 72, 1622-1631.
80. Emberley, E.D.; Murphy, L.C.; Watson, P.H. S100 proteins and their influence on pro-survival pathways in cancer. Biochem. Cell Biol. 2004, 82, 508-515.
81. Heizmann, C.W.; Ackermann, G.E.; Galichet, A. Pathologies involving the S100 proteins and RAGE. Subcell. Biochem. 2007, 45, 93-138.
82. Hermani, A.; de Servi, B.; Medunjanin, S.; Tessier, P.A.; Mayer, D. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp. Cell. Res. 2006, 312, 184-197.
83. Hermani, A.; Hess, J.; de Servi, B.; Medunjanin, S.; Grobholz, R.; Trojan, L.; Angel, P.; Mayer, D. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin. Cancer Res. 2005, 11, 5146-5152.
84. Ott, H.W.; Lindner, H.; Sarg, B.; Mueller-Holzner, E.; Abendstein, B.; Bergant, A.; Fessler, S.; Schwaerzler, P.; Zeimet, A.; Marth, C., et al. Calgranulins in cystic fluid and serum from patients with ovarian carcinomas. Cancer Res. 2003, 63, 7507-7514.
85. The Human Protein Atlas. Available online: http://www.proteinatlas.org (accessed on 28 November 2011).
86. Ghavami, S.; Rashedi, I.; Dattilo, B.M.; Eshraghi, M.; Chazin, W.J.; Hashemi, M.; Wesselborg, S.; Kerkhoff, C.; Los, M. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J. Leukoc. Biol. 2008, 83, 1484-1492.
87. Turovskaya, O.; Foell, D.; Sinha, P.; Vogl, T.; Newlin, R.; Nayak, J.; Nguyen, M.; Olsson, A.; Nawroth, P.P.; Bierhaus, A., et al. RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 2008, 29, 2035-2043.
88. Moon, A.; Yong, H.Y.; Song, J.I.; Cukovic, D.; Salagrama, S.; Kaplan, D.; Putt, D.; Kim, H.; Dombkowski, A.; Kim, H.R. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion. Mol. Cancer Res. 2008, 6, 1544-1553.
89. Cheng, P.; Corzo, C.A.; Luetteke, N.; Yu, B.; Nagaraj, S.; Bui, M.M.; Ortiz, M.; Nacken, W.; Sorg, C.; Vogl, T., et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med. 2008, 205, 2235-2249.
90. Sinha, P.; Okoro, C.; Foell, D.; Freeze, H.H.; Ostrand-Rosenberg, S.; Srikrishna, G. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J. Immunol. 2008, 181, 4666-4675.
91. Ichikawa, M.; Williams, R.; Wang, L.; Vogl, T.; Srikrishna, G. S100A8/A9 activate key genes and pathways in colon tumor progression. Mol. Cancer Res. 2011, 9, 133-148.
92. Gabrilovich, D.I.; Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009, 9, 162-174.
93. Ostrand-Rosenberg, S. Cancer and complement. Nat. Biotechnol. 2008, 26, 1348-1349.
94. van Zoelen, M.A.; Vogl, T.; Foell, D.; van Veen, S.Q.; van Till, J.W.; Florquin, S.; Tanck, M.W.; Wittebole, X.; Laterre, P.F.; Boermeester, M.A., et al. Expression and role of myeloid-related protein-14 in clinical and experimental sepsis. Am. J. Respir. Crit. Care Med. 2009, 180, 1098-1106.
95. Bianchi, M.E. DAMPs, PAMPs and alarmins: All we need to know about danger. J. Leukoc. Biol. 2007, 81, 1-5.
96. Zreiqat, H.; Belluoccio, D.; Smith, M.M.; Wilson, R.; Rowley, L.A.; Jones, K.; Ramaswamy, Y.; Vogl, T.; Roth, J.; Bateman, J.F., et al. S100A8 and S100A9 in experimental osteoarthritis. Arthritis Res. Ther. 2010, 12, doi:10.1186/ar2917.
97. Schelbergen, R.F.; Blom, A.B.; van den Bosch, M.H.; Sloetjes, A.; Abdollahi-Roodsaz, S.; Schreurs, B.W.; Mort, J.S.; Vogl, T.; Roth, J.; van den Berg, W.B.; et al. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on toll-like receptor 4. Arthritis Rheum. 2011, doi: 10.1002/art.33495.
98. van Lent, P.; Blom, A.; Schelbergen, R.; Sloetjes, A.; Lafeber, F.; Lems, W.; Cats, H.; Vogl, T.; Roth, J.; van den Berg, W. Active involvement of "alarmins" S100A8 and S100A9 in regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum. 2011, doi: 10.1002/art.34315.
99. Broome, A.M.; Ryan, D.; Eckert, R.L. S100 protein subcellular localization during epidermal differentiation and psoriasis. J. Histochem. Cytochem. 2003, 51, 675-685.
100. Wittkowski, H.; Kuemmerle-Deschner, J.B.; Austermann, J.; Holzinger, D.; Goldbach-Mansky, R.; Gramlich, K.; Lohse, P.; Jung, T.; Roth, J.; Benseler, S.M., et al. MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes. Ann. Rheum. Dis. 2011, 70, 2075-2081.
101. Bjork, P.; Bjork, A.; Vogl, T.; Stenstrom, M.; Liberg, D.; Olsson, A.; Roth, J.; Ivars, F.; Leanderson, T. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biol. 2009, 7, doi:10.1371/journal.pbio. 1000097.
102. Boyd, J.H.; Kan, B.; Roberts, H.; Wang, Y.; Walley, K.R. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ. Res. 2008, 102, 1239-1246.
103. Novitskaya, V.; Grigorian, M.; Kriajevska, M.; Tarabykina, S.; Bronstein, I.; Berezin, V.; Bock, E.; Lukanidin, E. Oligomeric forms of the metastasis-related Mts1 (S100A4) protein stimulate neuronal differentiation in cultures of rat hippocampal neurons. J. Biol. Chem. 2000, 275, 41278-41286.
104. Moroz, O.V.; Antson, A.A.; Dodson, E.J.; Burrell, H.J.; Grist, S.J.; Lloyd, R.M.; Maitland, N.J.; Dodson, G.G.; Wilson, K.S.; Lukanidin, E., et al. The structure of S100A12 in a hexameric form and its proposed role in receptor signalling. Acta Crystallogr. Sect. D Biol. Crystallogr. 2002, 58, 407-413.
105. Ostendorp, T.; Leclerc, E.; Galichet, A.; Koch, M.; Demling, N.; Weigle, B.; Heizmann, C.W.; Kroneck, P.M.H.; Fritz, G. Structural and functional insights into RAGE activation by multimeric S100B. EMBO J. 2007, 26, 3868-3878.
106. de Marzo, A.M.; Platz, E.A.; Sutcliffe, S.; Xu, J.; Gronberg, H.; Drake, C.G.; Nakai, Y.; Isaacs, W.B.; Nelson, W.G. Inflammation in prostate carcinogenesis. Nat. Rev. Cancer 2007, 7, 256-269.
107. Jager, G.J.; Ruijter, E.T.; de la Rosette, J.J.; van de Kaa, C.A. Amyloidosis of the seminal vesicles simulating tumor invasion of prostatic carcinoma on endorectal MR images. Eur. Radiol. 1997, 7, 552-554.
108. Christian, J.D.; Lamm, T.C.; Morrow, J.F.; Bostwick, D.G. Corpora amylacea in adenocarcinoma of the prostate: Incidence and histology within needle core biopsies. Mod. Pathol. 2005, 18, 36-39.
109. Bostwick, D.G.; Amin, M.B.; Dundore, P.; Marsh, W.; Schultz, D.S. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum. Pathol. 1993, 24, 298-310.
110. Untergasser, G.; Madersbacher, S.; Berger, P. Benign prostatic hyperplasia: Age-related tissue-remodeling. Exp. Gerontol. 2005, 40, 121-128.
111. Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature 2002, 420, 860-867.
112. Stefani, M. Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity. FEBS J. 2010, 277, 4602-4613.
113. Klimas, R.; Bennett, B.; Gardner, W.A., Jr. Prostatic calculi: A review. Prostate 1985, 7, 91-96.
114. Thomas, B.A. Vital factors in the management of prostatic obstruction. Ann. Surg. 1927, 86, 563-576.
115. Drach, G.W.; Fair, W.R.; Meares, E.M.; Stamey, T.A. Classification of benign diseases associated with prostatic pain: Prostatitis or prostatodynia? J. Urol. 1978, 120, 266.
116. Kayed, R.; Head, E.; Sarsoza, F.; Saing, T.; Cotman, C.W.; Necula, M.; Margol, L.; Wu, J.; Breydo, L.; Thompson, J.L., et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2007, 2, doi:10.1186/1750-1326-2-18.
117. McCormick, M.M.; Rahimi, F.; Bobryshev, Y.V.; Gaus, K.; Zreiqat, H.; Cai, H.; Lord, R.S.; Geczy, C.L. S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J. Biol. Chem. 2005, 280, 41521-41529.
118. Gharibyan, A.L.; Raveh, D.; Morozova-Roche, L.A. S100A8/A9 Amyloidosis in the Ageing Prostate: Relating ex vivo and in vitro Studies. In Amyloid Proteins: Methods and Protocols (Methods in Molecular Biology), 2nd ed.; Sigurdsson, E.M., Ed.; Humana Press: New York, NY, USA, 2012; Volume 849.
119. Nacken, W.; Roth, J.; Sorg, C.; Kerkhoff, C. S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc. Res. Tech. 2003, 60, 569-580.
120. Otzen, D.; Nielsen, P.H. We find them here, we find them there: Functional bacterial amyloid. Cell. Mol. Life Sci. 2008, 65, 910-927.